CORD-19:e847d433e7424152a9846673209cb73027415ecd / 33314-33661
Annnotations
CORD-19-Sentences
{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T305","span":{"begin":0,"end":347},"obj":"Sentence"},{"id":"T45968","span":{"begin":0,"end":347},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"This evaluation provides convincing evidence that the performance of antimicrobial susceptibility tests for ERT, GAR, and TEL on the VITEKÒ2 platform is comparable to conventional testing in a clinical laboratory. typing (MLST), SCCmec typing, antimicrobial susceptibility testing, and PCR for detection of Panton-Valentine leukocidin (PVL) genes."}
CORD-19_Custom_license_subset
{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T305","span":{"begin":0,"end":347},"obj":"Sentence"}],"text":"This evaluation provides convincing evidence that the performance of antimicrobial susceptibility tests for ERT, GAR, and TEL on the VITEKÒ2 platform is comparable to conventional testing in a clinical laboratory. typing (MLST), SCCmec typing, antimicrobial susceptibility testing, and PCR for detection of Panton-Valentine leukocidin (PVL) genes."}
CORD-19-PD-MONDO
{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T78","span":{"begin":336,"end":339},"obj":"Disease"},{"id":"T62614","span":{"begin":336,"end":339},"obj":"Disease"}],"attributes":[{"id":"A78","pred":"mondo_id","subj":"T78","obj":"http://purl.obolibrary.org/obo/MONDO_0015742"},{"id":"A20490","pred":"mondo_id","subj":"T62614","obj":"http://purl.obolibrary.org/obo/MONDO_0015742"}],"text":"This evaluation provides convincing evidence that the performance of antimicrobial susceptibility tests for ERT, GAR, and TEL on the VITEKÒ2 platform is comparable to conventional testing in a clinical laboratory. typing (MLST), SCCmec typing, antimicrobial susceptibility testing, and PCR for detection of Panton-Valentine leukocidin (PVL) genes."}